(VIANEWS) - Stellus Capital Investment Corporation (SCM), Stepan Company (SCL), Ingredion Incorporated (INGR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Stellus Capital Investment Corporation (SCM)
17.2% sales growth and 13.05% return on equity
Stellus Capital Investment Corporation is a business development company specializing in investments in private middle-market companies.
Stellus Capital Investment Corporation's sales growth this year is expected to be 7.3% and 8.6% for next year.
Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 56.65M for the twelve trailing months.
Volume
Today's last reported volume for Stellus Capital Investment Corporation is 66361 which is 18.54% above its average volume of 55981.
Stellus Capital Investment Corporation's sales growth for the next quarter is 17.2%. The company's growth estimates for the current quarter and the next is 3.7% and 7.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.05%.
Volatility
Stellus Capital Investment Corporation's last day, last week, and last month's current volatility was 0.29%, 0.71%, and 0.73%, respectively.
Stellus Capital Investment Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.05% (day), 1.56% (last week), and 1.65% (last month), respectively.
Stellus Capital Investment Corporation's Stock Yearly Top and Bottom Value
Stellus Capital Investment Corporation's stock is valued at $13.95 at 01:22 EST, below its 52-week high of $13.98 and way higher than its 52-week low of $8.25.
Stellus Capital Investment Corporation's Moving Average
Stellus Capital Investment Corporation's worth is higher than its 50-day moving average of $13.39 and higher than its 200-day moving average of $13.20.2. Stepan Company (SCL)
9.5% sales growth and 15.19% return on equity
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia.
Stepan Company's sales growth this year is expected to be 19.3% and 2.9% for next year.
Year-on-year quarterly revenue growth grew by 29.8%, now sitting on 2.23B for the twelve trailing months.
Volume
Today's last reported volume for Stepan Company is 45273 which is 39.94% below its average volume of 75386.
Stepan Company's sales growth is a negative 0% for the ongoing quarter and 9.5% for the next. The company's growth estimates for the current quarter and the next is 5.8% and negative -0.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.19%.
Volatility
Stepan Company's last day, last week, and last month's current volatility was 0.08%, 0.98%, and 0.99%, respectively.
Stepan Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.46% (day), 1.85% (last week), and 2.01% (last month), respectively.
Stepan Company's Stock Yearly Top and Bottom Value
Stepan Company's stock is valued at $120.12 at 01:22 EST, way below its 52-week high of $139.30 and way above its 52-week low of $109.08.
Stepan Company's Moving Average
Stepan Company's value is higher than its 50-day moving average of $116.40 and below its 200-day moving average of $122.69.3. Ingredion Incorporated (INGR)
7.6% sales growth and 5.27% return on equity
Ingredion Incorporated, together with its subsidiaries, produces and sells starches and sweeteners for various industries.
Ingredion Incorporated's sales growth this year is anticipated to be 13.3% and 3.6% for next year.
Year-on-year quarterly revenue growth grew by 30.6%, now sitting on 6.47B for the twelve trailing months.
Volume
Today's last reported volume for Ingredion Incorporated is 479057 which is 30.83% above its average volume of 366161.
Ingredion Incorporated's sales growth for the next quarter is 7.6%. The company's growth estimates for the present quarter and the next is a negative 18.1% and negative -21.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.27%.
Volatility
Ingredion Incorporated's last day, last week, and last month's current volatility was 0.17%, 0.89%, and 0.85%, respectively.
Ingredion Incorporated's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.33% (day), 1.51% (last week), and 1.68% (last month), respectively.
Ingredion Incorporated's Stock Yearly Top and Bottom Value
Ingredion Incorporated's stock is valued at $95.23 at 01:22 EST, below its 52-week high of $98.05 and way above its 52-week low of $68.71.
Ingredion Incorporated's Moving Average
Ingredion Incorporated's worth is higher than its 50-day moving average of $92.32 and higher than its 200-day moving average of $91.41.4. Ameren (AEE)
5.9% sales growth and 10.4% return on equity
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States.
Ameren's sales growth this year is anticipated to be 6.1% and 4.4% for next year.
Year-on-year quarterly revenue growth grew by 5.5%, now sitting on 5.74B for the twelve trailing months.
Volume
Today's last reported volume for Ameren is 520389 which is 46.42% below its average volume of 971312.
Ameren's sales growth for the next quarter is 5.9%. The company's growth estimates for the ongoing quarter and the next is 8.8% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.4%.
Volatility
Ameren's last day, last week, and last month's current volatility was 1.04%, 0.70%, and 1.32%, respectively.
Ameren's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.65% (day), 1.17% (last week), and 1.46% (last month), respectively.
Ameren's Stock Yearly Top and Bottom Value
Ameren's stock is valued at $84.81 at 01:22 EST, under its 52-week high of $90.77 and way higher than its 52-week low of $69.79.
Ameren's Moving Average
Ameren's worth is higher than its 50-day moving average of $83.68 and higher than its 200-day moving average of $84.47.5. CrossFirst Bankshares (CFB)
5.6% sales growth and 7.02% return on equity
CrossFirst Bankshares's sales growth this year is expected to be 8.6% and 2.4% for next year.
Year-on-year quarterly revenue growth grew by 87.1%, now sitting on 146.53M for the twelve trailing months.
Volume
Today's last reported volume for CrossFirst Bankshares is 155099 which is 102.78% above its average volume of 76485.
CrossFirst Bankshares's sales growth for the next quarter is 5.6%. The company's growth estimates for the current quarter and the next is 100% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.02%.
Volatility
CrossFirst Bankshares's last day, last week, and last month's current volatility was 3.38%, 1.36%, and 1.19%, respectively.
CrossFirst Bankshares's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 5.21% (day), 3.78% (last week), and 2.97% (last month), respectively.
CrossFirst Bankshares's Stock Yearly Top and Bottom Value
CrossFirst Bankshares's stock is valued at $13.90 at 01:22 EST, way under its 52-week high of $15.67 and way higher than its 52-week low of $8.25.